Consilium Medicum

Peer-review medical journal

ISSN (print): 2075-1753ISSN (online): 2542-2170

Media registration certificate: ЭЛ № ФС 77 - 69134 от 24.03.2017

Founder: Closed Joint Stock Company "Medical Publications"

Number of issues per year: 12

Access: Open

Included in: White List (3 level), RISC, Higher Attestation Commission List

Editor-in-chief

Publisher

About

Professional medical multidisciplinary journal , based on the principles of evidence-based medicine. Consilium Medicum magazine has been issued since 1999.

The journal publishes national and international recommendations, reviews, lectures, original works, and clinical cases dealing with the most actual problems of the modern medicine, as well as interviews with experts within the different fields of medicine and conferences, congresses and forums reviews.

The journal is practically-oriented and publishes articles by leading clinicians who are professional in the special field of medicine in Russia, Ukraine, Belarus, and includes the high level of scientific information.

Consilium Medicum journal is the most popular journal among medical practitioners. There are 12 thematic issues per year. The journal is designed for therapeutists, pediatricians, cardiologists, endocrinologists, gastroenterologists, pulmonologists, dermatologists, obstetrician-gynecologists, urologists, nephrologists, neurologists, rheumatologists and physicians in other specialties, as well as for resident physicians, post-graduate students and senior students at medical universities.

Types of accepted articles

  • reviews, systematic reviews and meta-analysis
  • original research
  • clinical case reports and series of clinical cases
  • letters to the editor
  • hystorical articles in medicine

Research fields

  • Internal medicine
  • Endocrinology
  • Otorhinolaryngology
  • Cardiology
  • Neurology
  • Phthisiology
  • Surgery
  • Rheumatology
  • Urology
  • Pulmonology
  • Gastroenterology
  • Gerontology and geriatrics

Publication, distribution and indexation

  • Russian and English full-text articles;
  • issues publish monthly, 12 times per year;
  • no APC, Platinum Open Access
  • articles distributr under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (CC BY-NC-SA 4.0).

Indexation

  • Russian Science Citation Index (elibrary.ru)
  • DOAJ
  • CrossRef
  • Google Scholar
  • WorldCat
  • Ulrich's Periodicals Directory
  • CyberLeninka

Current Issue

Vol 27, No 2 (2025): Neurology and Rheumatology

Articles

Reversible cerebral vasoconstriction syndrome: A review
Kulesh A.A., Demin D.A., Starikova N.L., Mekhryakov S.A., Kayleva N.A.
Abstract

Reversible cerebral vasoconstriction syndrome is a relevant but poorly recognized cause of ischemic stroke in young patients. The syndrome should be suspected in patients with recurrent headaches (especially thunderclap headaches) associated with focal neurological deficits, epileptic seizures, or changes in mental status; taking history for any vasoactive triggers is crucial. The radiological spectrum of reversible cerebral vasoconstriction syndrome is broad and includes infarctions, intracerebral and subarachnoid hemorrhages, as well as posterior reversible encephalopathy. These patterns can unfold during the first 2 weeks, which requires serial neuroimaging; early signs include hyperintensity of the arteries on FLAIR. Delayed serial angiography showing reversible multifocal segmental vasoconstriction is required for verification.

Consilium Medicum. 2025;27(2):63-69
pages 63-69 views
Migraine and antiphospholipid syndrome: The change of headache during pregnancy and the postpartum period
Dashdamirova L.R., Voskresenskaya O.N., Khizroeva J.K., Spektor E.D.
Abstract

Background. The course of migraine is characterized by sensitivity to hormonal changes, which is particularly evident in the reduced frequency and severity of attacks during pregnancy and lactation. This phenomenon is attributed to the suppression of the menstrual cycle and the associated changes in estradiol levels. The pathogenesis of migraine in patients with antiphospholipid syndrome and genetic thrombophilia (APS/GT) differs by the predominance of hypercoagulative and platelet components. Consequently, pregnancy might exacerbate the severity of migraine in these patients.

Aim. To assess the course of migraine during pregnancy, lactation and the postpartum period in patients with APS/GT.

Materials and methods. The study included female patients aged 18 to 50 years diagnosed with migraine. Based on the presence of APS/GT, the study sample was divided into two groups: female patients with APS/GT and migraine (group 1) and female patients with migraine without APS/GT (group 2). The disease history and obstetric-gynecological history were assessed. For those with a history of pregnancy, the number of headache episodes per month during pregnancy, breastfeeding, and one year after delivery was recorded. The study included 68 women, with 36 (52.9%) in group 1 and 32 (47.1%) in group 2. A history of pregnancy and childbirth was noted in 54 (87.1%) patients (31 from group 1 and 23 from group 2).

Results. In group 2, pregnancy was associated with a reduction in headache frequency, up to complete remission in most patients during the second and third trimesters and lactation. One year postpartum, headache frequency was comparable to pre-pregnancy levels. In group 1, a reduction in headache frequency was observed during the first, second, and third trimesters, similar to group 2, but with statistically significantly less pronounced improvement in migraine course.

Conclusion. The presence of APS/GT neutralizes the positive effects of pregnancy and lactation on migraine. However, no exacerbation of migraine was observed in patients with APS/GT in this study, which may be attributed to anticoagulant therapy administered during pregnancy.

Consilium Medicum. 2025;27(2):70-74
pages 70-74 views
Migraine with prolonged aura vs migraine-associated stroke: a case series. Case report
Kulesh A.A., Starikova N.L., Demin D.A., Krapivin S., Mekhriakov S.A., Kaileva N.A., Lezhikova M.V.
Abstract

The article presents three clinical cases of patients with migraine with aura and long-term focal symptoms without the formation of ischemic foci. A case of migraine-associated stroke is presented for comparison. The presented cases indicate that admission to the hospital of a patient with a history of migraine and a focal neurological deficit is a challenging clinical situation that requires individualization of diagnostic and therapeutic tactics. In the presence of a prolonged aura, CT perfusion, and diffusion-weighted magnetic resonance imaging, can contribute to an informed clinical decision. The MRI findings should be interpreted cautiously since transient cortical edema may be associated with aura prolongation. If it is impossible to differentiate reliably between migraine and stroke in a short time, intravenous thrombolysis should be performed.

Consilium Medicum. 2025;27(2):75-80
pages 75-80 views
Non-surgical treatment of cervical radiculopathy in outpatient settings. Case report
Isaikin A.I., Kerimova E.K., Mouki K.
Abstract

Cervical radiculopathy (CR) occurs when the cervical spinal roots are compressed due to degenerative changes in vertebral structures. At the cervical level, compression of radicular structures is most often caused not by the "soft tissue" component of the herniated disc in the epidural space but by compression in the radicular opening itself due to spondylosis. CR can present with various clinical symptoms and their combination in the form of not only pain (usually with "distant" radiation) but also symptoms of dysfunction (hypoaesthesia, motor disorders, decreased tendon reflexes) in the innervation zone of the corresponding spinal roots. Challenge tests aimed at increasing root compression and enhancing clinical symptoms (Spurling, Valsalva, and Elvey tests – Upper Limb Tension Tests, ULTT) are used, as well as other tests to reduce the root compression and relieve pain (traction, shoulder abduction). The diagnosis is based on the analysis of clinical presentation. Root compression is unlikely in the absence of focal neurological symptoms. Native magnetic resonance imaging of the cervical spine is the mainstay of neuroimaging for patients with a new or worsening clinical presentation of non-traumatic CR in the absence of "red flags." When assessing radicular compression, neuroimaging data should be interpreted only in the context of clinical presentation. The presence of anxiety, depression, distress symptoms, and high demands at work is associated with a poor prognosis of recovery and a decrease in the quality of life in patients with CR. Most doctors do not pay enough attention to assessing psychosocial factors. To facilitate this assessment, we have developed a telegram bot. The CR has a naturally favorable course and prognosis. In most cases, CR is a spontaneously resolving condition with a full recovery rate of 83-90%. The method of choice is non-surgical treatment. A case of typical CR is presented. A comprehensive multidisciplinary treatment, including clarification, an educational program, physical therapy, manual therapy, as well as drug therapy (non-steroidal anti-inflammatory drugs, gabapentin, Combilipen) is effective in regression of pain, neurological symptoms, improvement of psycho-emotional status, functional abilities, and quality of life.

Consilium Medicum. 2025;27(2):81-87
pages 81-87 views
Assessment of the quality of life of pediatric patients with multiple sclerosis
Akhmetgaleeva N.F., Simaniv T.O., Bakhtiyarova K.Z.
Abstract

Background. Multiple sclerosis (MS) is a chronic Demyelinating disease, the onset of MS occurs in childhood in 5% of cases. MS has a great impact on the quality of life (QoL) of children, especially during periods of exacerbation of the disease.

Aim. To assess the quality of life of pediatric patients with MS and identification the factors that have impact on it.

Materials and methods. Examined 22 patients with MS in exacerbation and remission (no exacerbations for 6 months) and 20 healthy children, comparable in gender and age. The quality of life of children was assessed using the Pediatric Quality of Life Questionnaire – PedsQL 4.0.

Results. QoL of children have significally decreased during exacerbation of MS compared with remission (p<0.001). The indicators of QoL in remission of MS are not differ from those in healthy controls (p=0.294). QoL in children with MS during the period of exacerbation is lower than in healthy controls (p<0.001). Lower QoL is associated with more disability on the EDSS scale. The duration of the MS and the age of onset do not affect the QoL of patients.

Conclusion. Exacerbations of multiple sclerosis reduce the quality of life of children, and QoL decrease correlates with the severity of neurological deficits. When remission is achieved and maintained, the quality of life is restored and does not differ from that of healthy children.

Consilium Medicum. 2025;27(2):88-93
pages 88-93 views
Cervicalgia and cervicobrachialgia in periarticular cyst at the cervical level. Case report
Kerimova E.K., Isaikin A.I., Romanova A.S., Bashlachev M.G., Mouki K.
Abstract

Periarticular cysts (PAC) at the level of the cervical spine are rare and cause difficulties in diagnosis. The article presents an observation of a 72-year-old patient with spinal canal stenosis at the C7-Th1 level due to a PAC at the C7-Th1 level on the right, compression-ischemic radiculopathy C8 on the right. For 10 months, the cause of radiculopathy at the cervical level was not determined, and there was no effect from the treatment. The patient was prescribed repeated courses of drug treatment, physiotherapy, massage, diagnostic injections and blockages, while not considering the possibility of a PAC in which surgical treatment is most effective. The detection of a PAC, its surgical treatment, followed by kinesiotherapy led to a complete regression of pain syndrome within 3 months. The issues of pathogenesis, diagnosis and treatment of PAC of the cervical spine are discussed.

Consilium Medicum. 2025;27(2):94-98
pages 94-98 views
Algorithms for the treatment of patients with chronic cerebral ischemia of stages I and II with use of Picamilon: results of an open clinical comparative study
Danilov A.B., Shindryaeva N.N., Borodulina I.V., Lunegov T.D.
Abstract

Aim. To study the efficacy and safety of Picamilon in patients with stages I and II of chronic cerebral ischemia (CCI).

Materials and methods. An open comparative clinical trial included 100 patients who were divided into 2 groups depending on the stage of CCI: n=50 (group 1 with CCI stage I); n=50 (group 2 with CCI stage II, average age 62.2±8.98 years). Group 1 patients were also divided into subgroups 1A (mean age 55.6±6.76 years) and 1B (mean age 52.8±6.11 years), which used different treatment regimens. The patients were prescribed the drug Picamilon, the total duration of therapy in group 1 was 60 days, in group 2 – 70 days. The study included 4 visits: before treatment, 10 days later, at the end of therapy (60/70 days later), 1.5 months after the end of treatment. The study was conducted using the Montreal Cognitive Function Assessment Scale (MoCA), the A.M. Wein scale of autonomic disorders, the A.I. Fedin scale of neurological disorders, and the Ya.I. Levin Sleep Quality Scale. The condition of cerebral blood flow (Dopplerography of intracranial vessels) and endothelial function (levels of methylated forms of arginine – ADMA, MMA, SDMA and their ratios) were assessed. Adverse events on the background of therapy and the tolerability of treatment were recorded.

Results. During treatment, statistically significant cognitive improvement on the MoCA scale (p=0.022 and p<0.0001) was observed in groups of patients with different stages of CCI, increasing in the delayed period: more than 80% of patients in the general sample reached the normal level when assessed in the long-term period. Patients with CCI II initially have a worse cognitive status, while their average score growth is significantly higher compared to CCI I. Autonomic symptoms significantly decrease, regardless of the stage of CCI and the treatment regimen: improvement in 29% and 38% of patients with CCI stages I and II, respectively. Positive dynamics of neurological functions was noted in 77% (CCI I) and 84% (CCI II) of patients, the effect of treatment increases in the delayed period (p<0.05). Patients with CCI II initially have a more pronounced neurological deficit, however, during treatment, the average decrease on the CCI Fedin A.I. scale is statistically significantly higher (p=0.037) than in patients with CCI I. In both groups of patients, there is a statistically significant comparable positive trend (decrease) in the severity of sleep disorders, increasing in the delayed period. In subgroup 1B (with parenteral therapy at the start), 28% of patients improved sleep quality by Visit 2 compared to 11% in subgroup 1A, and by the end of the course of therapy (Visit 3), the effect in the groups was comparable. The majority of patients (98%) noted good tolerability and comfort of therapy, while the groups and subgroups did not differ (p>0.05). Picamilon has an effect on cerebral hemodynamic parameters: against the background of therapy, the proportion of patients who have achieved normalization of hemodynamic parameters increases: up to 100% when assessing Vmax and resistance index and up to 93% when assessing pulsation index; the thickness of the intimate media complex is significantly reduced. Picamilon reduces concentrations of markers of endothelial dysfunction – initially elevated levels of ADMA in both groups and SDMA in group 2.

Conclusion. The use of Picamilon is effective in patients with stages I and II CCI, contributes to significant regression of cognitive impairment, neurological deficit, improvement of sleep quality and stabilization of autonomic function; improves vascular endothelial function, reduces the risk of atherosclerosis and cardiovascular complications in patients. The optimal duration of Picamilon therapy in CCI is 2–2.5 months, depending on the stage of the disease.

Consilium Medicum. 2025;27(2):99-111
pages 99-111 views
The effect of anxiety and depressive disorders on pain intensity, quality of life, and physical activity in patients with chronic non-specific neck and low back pain
Mukhametzyanova A.K., Petelin D.S., Isaikin A.I.
Abstract

Background. Chronic neck and low back pain is characterized by high comorbidity with anxiety and depressive disorders, which can exacerbate pain. The usefulness of psychiatrist involvement in the management of patients with chronic non-specific neck and low back pain has been poorly studied.

Aim. To study the effect of anxiety and depressive disorder on pain intensity, physical activity, and quality of life in patients with nonspecific neck and low back pain, as well as the feasibility of involving a psychiatrist in the examination of patients.

Materials and methods. The study included 43 patients (11 men and 32 women, average age 56.2±13.3 years) with chronic nonspecific neck and low back pain, who were diagnosed with increased anxiety or depression using the Spielberg test and/or the Beck depression questionnaire. All patients were consulted by a psychiatrist. A numerical rating scale was used to assess pain intensity, an international questionnaire on physical activity was used to analyze the level of physical activity, a central sensitization questionnaire was used to diagnose central sensitization, and the Spielberger test with an assessment of reactive (RA) and personal anxiety, and the Beck depression questionnaire were used to assess anxiety and depressive disorders. The SF-12 questionnaire was used to assess the quality of life, taking into account the division of this questionnaire into consolidated scales of physical and mental health.

Results. Based on an in-person consultation with a psychiatrist, the following diagnoses were established according to ICD-10: F32 "Depressive episode" in 11 patients, F33 "Recurrent depressive disorder" in 14 patients, F41.1 "Generalized anxiety disorder" in 11 patients, F41.0 "Panic disorder" in 1 patient, F41.2 "Mixed anxiety and depressive disorder" in 4 patients, F41.9 "Anxiety disorder, unspecified" in 1 patient, F40.0 "Agoraphobia" in 1 patient. A negative impact of anxiety and depression on both the intensity of pain and the quality of life of patients was found. A relationship was found between pain intensity and the severity of depression (β=0.048; p=0.008; 95% CI 0.013–0.084) and RA (β=0.052; p=0.007; 95% CI 0.015–0.089). A negative impact of depression (β=-0.424; p=0.004; 95% CI -0.702–-0.144) and RA (β=-0.365; p=0.020; 95% CI -0.688–-0.061) on physical activity was shown. A negative impact on the mental component of quality of life was found for depression (β=-0.414; p=0.005; 95% CI -0.698–-0.129), RA (β=-0.437; p=0.005; 95% CI -0.735–-0.138) and personal anxiety (β=-0.364; p=0.007; 95% CI -0.625–-0.103).

Conclusion. Anxiety and depressive disorders increase the intensity of pain syndrome, reduce physical activity and quality of life in patients with chronic nonspecific neck and low back pain. A psychiatric consultation allows you to diagnose a specific mental disorder.

Consilium Medicum. 2025;27(2):112-116
pages 112-116 views
Case report: neuroses in children and adolescents
Consilium Medicum. 2025;27(2):117-118
pages 117-118 views
Artificial intelligence in neuroscience: opportunities and prospects: A review
Rezvanova A.A., Kovalchuk N.A.
Abstract

The review examines practical examples of the use of artificial intelligence in the diagnosis of neurological diseases such as stroke, traumatic brain injuries, neurodegenerative diseases, including Parkinson's disease, Alzheimer's disease, multiple sclerosis, as well as epilepsy and sleep disorders. The basic concepts of AI and machine learning, the problems associated with their implementation, and the prospects for further development of technologies aimed at improving the accuracy and effectiveness of medical care in neurology are discussed.

Consilium Medicum. 2025;27(2):119-122
pages 119-122 views
Difficulties in the oncology diagnosis with systemic sclerosis. Сase report
Menshikova I.V., Sobyanina A.N., Prokofieva Y.A., Kolosova I.R.
Abstract

Systemic sclerois (SS) is a relatively rare immunoinflammatory disease characterized by vasculopathy, immune abnormalities and generalized fibrosis. The prevalence of cancer in SS ranges from 3 to 11%, with tumors most commonly identified in the lung or gastrointestinal tract. Despite regular follow-up of patients with SS by rheumatologists, the oncologic process is often diagnosed at late stages. We describe the clinical observation of a 71-year-old patient with a long history of SS in whom the tumor process was detected at the stage of bone metastases, and morphological verification was difficult.

Consilium Medicum. 2025;27(2):123-128
pages 123-128 views

Согласие на обработку персональных данных с помощью сервиса «Яндекс.Метрика»

1. Я (далее – «Пользователь» или «Субъект персональных данных»), осуществляя использование сайта https://journals.rcsi.science/ (далее – «Сайт»), подтверждая свою полную дееспособность даю согласие на обработку персональных данных с использованием средств автоматизации Оператору - федеральному государственному бюджетному учреждению «Российский центр научной информации» (РЦНИ), далее – «Оператор», расположенному по адресу: 119991, г. Москва, Ленинский просп., д.32А, со следующими условиями.

2. Категории обрабатываемых данных: файлы «cookies» (куки-файлы). Файлы «cookie» – это небольшой текстовый файл, который веб-сервер может хранить в браузере Пользователя. Данные файлы веб-сервер загружает на устройство Пользователя при посещении им Сайта. При каждом следующем посещении Пользователем Сайта «cookie» файлы отправляются на Сайт Оператора. Данные файлы позволяют Сайту распознавать устройство Пользователя. Содержимое такого файла может как относиться, так и не относиться к персональным данным, в зависимости от того, содержит ли такой файл персональные данные или содержит обезличенные технические данные.

3. Цель обработки персональных данных: анализ пользовательской активности с помощью сервиса «Яндекс.Метрика».

4. Категории субъектов персональных данных: все Пользователи Сайта, которые дали согласие на обработку файлов «cookie».

5. Способы обработки: сбор, запись, систематизация, накопление, хранение, уточнение (обновление, изменение), извлечение, использование, передача (доступ, предоставление), блокирование, удаление, уничтожение персональных данных.

6. Срок обработки и хранения: до получения от Субъекта персональных данных требования о прекращении обработки/отзыва согласия.

7. Способ отзыва: заявление об отзыве в письменном виде путём его направления на адрес электронной почты Оператора: info@rcsi.science или путем письменного обращения по юридическому адресу: 119991, г. Москва, Ленинский просп., д.32А

8. Субъект персональных данных вправе запретить своему оборудованию прием этих данных или ограничить прием этих данных. При отказе от получения таких данных или при ограничении приема данных некоторые функции Сайта могут работать некорректно. Субъект персональных данных обязуется сам настроить свое оборудование таким способом, чтобы оно обеспечивало адекватный его желаниям режим работы и уровень защиты данных файлов «cookie», Оператор не предоставляет технологических и правовых консультаций на темы подобного характера.

9. Порядок уничтожения персональных данных при достижении цели их обработки или при наступлении иных законных оснований определяется Оператором в соответствии с законодательством Российской Федерации.

10. Я согласен/согласна квалифицировать в качестве своей простой электронной подписи под настоящим Согласием и под Политикой обработки персональных данных выполнение мною следующего действия на сайте: https://journals.rcsi.science/ нажатие мною на интерфейсе с текстом: «Сайт использует сервис «Яндекс.Метрика» (который использует файлы «cookie») на элемент с текстом «Принять и продолжить».